+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-09-14Number of Pages: 67

Tissue Engineered Skin Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Tissue Engineered Skin Substitutes Market: Snapshot 

The elderly are highly prone to contracting skin diseases such as various forms of ulcers due to their significantly reduced flow of blood and overall immunity against diseases. The number of geriatrics in all nations has been on the rise owing to multiple factors, and a rise in their number is a direct call to action for all related healthcare organizations, products, and services. This includes the tissue engineered skin substitute providers and makes the above the top driver for its market.

The number of patients suffering from skin diseases and ulcers is also increasing within younger demographics. The CDC, for instance, stated in 2015 that close to 900,000 people are affected by DVT per year. A large number of patients were additionally being diagnosed with venous diseases per year, further boosting the need for tissue engineered skin substitutes.

The market is, however, restrained by over competitiveness between local manufacturers and their globally prominent counterparts. The local manufacturers can offer tissue engineered skin substitutes at a much lower price than global ones, forcing the latter to drop prices and consequently their profit margins. This will affect the market’s rate of research and development in the long run.

These drivers and restraints are expected to converge to result in a CAGR of 17.2% for the global market of tissue engineered skin substitutes between 2015 and 2023. This market is expected to be valued at US$1.24 bn by the end of 2016, and US$3.87 bn by 2023.

North America Continues to Show Strong Demand for Tissue Engineered Skin Substitutes

The need for tissue engineered skin substitutes in North America has consistently been high over the past few years. It is expected to generate US$1.96 bn in revenue for tissue engineered skin substitute players by 2023. A key reason prompting the use of tissue engineered skin substitutes in North America is the very high prevalence of vascular diseases. The region holds an especially high proportion of the geriatric, diabetic, and obese demographics and thus requires tissue engineered skin substitutes to a higher degree than other major regions.

Europe is another key region for tissue engineered skin substitute players. This region shows a similarly high demand as that shown by North America, although at a smaller revenue cap. The highest demand for tissue engineered skin substitutes at the moment, however, comes from Asia Pacific. The revenue earned by tissue engineered skin substitute providers in this region is expected to progress at a CAGR of 18.3% from 2015 to 2023. Key reasons for the high proliferation of tissue engineered skin substitute players in Asia Pacific is the growing geriatric population in nations such as South Korea and Japan, along with the rapidly increasing investments made by governments into the market.

Tissue Engineered Skin Substitutes to Find Increasing Demand in Treatment of Ulcers

Ulcers have consistently been the leading application segment for tissue engineered skin substitutes. By the end of 2023, nearly US$2.1 bn will be generated by tissue engineered skin substitute players through ulcer treatment alone. This segment is also expected to grow at a robust CAGR of 17.5% within 2015 and 2023.

The same applies to other skin disorders that are growing in prevalence across the globe. Most dermatology organizations such as the ADA have made their predictions, all of which point to a growing number of patients with skin disorders. The ADA, for instance, in 2013, released findings of a study that stated at least one in every five U.S. citizens will suffer from a skin disorder in their lifetime. This makes the development of dermatology solutions such as tissue engineered skin substitutes a matter of high concern.

The key manufacturers of tissue engineered skin substitutes include Acelity, Smith & Nephew, Molnlycke, ConVatec, Medtronic, and BSN Medical.

 

Chapter 1 Preface
1.1 Overview
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Comparative Analysis: Global Tissue Engineered Skin Substitutes Market, by Geography, 2014 and 2023 (Value %)
2.2 Global Tissue Engineered Skin Substitutes Market, by Type, 2014 (USD Million)
2.3 Market Snapshot: Global Tissue Engineered Skin Substitutes Market (2014 & 2023)

Chapter 3 Industry Analysis
3.1 Overview
3.2 Market Drivers
      3.2.1 Rise in Geriatric Population
      3.2.2 Increasing Incidence rate of Skin disorders
      3.2.3 Growing Medical tourism and medspas
3.3 Restraints
      3.3.1 Competitive Pricing and Equipment Costs
3.4 Opportunities
      3.4.1 Emerging Economies to Offer Sustained Growth Opportunities
      3.4.2 New Products, Services, and Device Development
3.5 Porter’s Five Force Analysis: Global Tissue Engineered Skin Substitutes Market
      3.5.1 Bargaining power of suppliers
      3.5.2 Bargaining power of buyers
      3.5.3 Threat of substitutes
      3.5.4 Threat of new entrants
      3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Tissue Engineered Skin Substitutes Market, by Geography
3.7 Competitive Landscape 
      3.8.1 Global Tissue Engineered Skin Substitute Market, by Key, Players, 2014 (%)

Chapter 4 Global Tissue Engineered Skin Substitutes Market Revenue, by Type
4.1 Overview
      4.1.1 Global Tissue Engineered Skin Substitutes Market Revenue, 2013–2023 (US$ Mn) 
4.2 Acellular Skin substitute
      4.2.1 Global Acellular Skin Substitutes Market Revenue, 2013–2023 (US$ Mn)
4.3 Cellular Allogeneic
      4.3.1 Global Cellular Allogeneic Skin Substitute Market Revenue, 2013 – 2023 (USD Million)
4.4 Cellular Autologous 
      4.4.1 Global Cellular Autologous Skin Substitute Market Revenue, 2013 – 2023 (USD Million)

Chapter 5 Global Tissue Engineered Skin Substitutes Market Revenue, by Application
5.1 Overview
      5.1.1 Global Tissue Engineered Skin Substitutes Market Revenue, by Application, 2013 – 2023 (USD Million)
5.2 Burns
      5.2.1 Global Burns Skin Substitute Market Revenue, 2013 – 2023 (USD Million)
5.3 Diabetic/Vascular Ulcers
      5.3.1 Global Diabetic/Vascular Ulcers Skin substitute Market Revenue, 2013 – 2023 (USD Million)
5.4 Others
      5.4.1 Global Others Skin substitute Market Revenue, 2013 – 2023 (USD Million)

Chapter 6 Global Tissue Engineered Skin Substitutes Market Revenue, by Geography
6.1 Overview
      6.1.1 Global Tissue Engineered Skin Substitutes Market Revenue, by Geography, 2013 – 2023 (USD Million)
6.2 North America
      6.2.1 North America Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.3 Europe
      6.3.1 Europe Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.4 Asia Pacific
      6.4.1 Asia Pacific Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.5 Latin America (LATAM)
      6.5.1 Latin Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)
6.6 Middle East and Africa (MEA)
      6.6.1 Middle East Africa (MEA) Tissue Engineered Skin Substitutes Market Revenue, by Country, 2013 – 2023 (USD Million)

Chapter 7 Recommendations
7.1 Research and Development Initiatives to Penetrate in the Market
7.2 Sustaining Pricing Pressures in a Declining Global Economic Scenario

Chapter 8 Company Profiles
8.1 Acelity L.P., Inc.
8.2 BSN medical
8.3 Integra LifeSciences Corporation
8.4 Medtronic (Covidien)
8.5 Mölnlycke Health Care
8.6 Smith & Nephew plc
8.7 Organogenesis, Inc

 

Tissue engineered skin substitutes are cellular and acellular materials that aid in the healing of damaged skin by releasing cytokines and growth factors at the wound site. Skin substitutes or artificial skin substitute are derived from human tissue, non-human tissue, synthetic materials, and combination of the above materials. This report studies the current scenario as well as future market potential for tissue engineered skin substitutes globally. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global tissue engineered skin substitutes market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players (%) operating in the tissue engineered skin substitutes market. 

Based on type, the global tissue engineered skin substitutes market has been segmented into acellular, cellular allogeneic, cellular autologous and others. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on application, the global tissue engineered skin substitutes market has been segmented into burn injury, diabetic/vascular ulcer and others. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the tissue engineered skin substitutes market has been categorized into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the tissue engineered skin substitutes market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include 3M Health Care, BSN medical, Medtronic, Acelity, L.P., Inc., Mölnlycke Health and Integra LifeSciences Corporation. 

The global tissue engineered skin substitutes market is segmented as follows:

  • Global Tissue Engineered Skin Substitutes Market, by Type
    • Acellular
    • Cellular Allogeneic
    • Cellular Autologous
    • Others
  • Global Tissue Engineered Skin Substitutes Market, by Application
    • Burn Injury
    • Diabetic/Vascular Ulcer
    • Others
  • Global Tissue Engineered Skin Substitutes Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K
      • Germany
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • Rest of APAC
    • Latin America (LATAM)
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa (MEA)
      • South Africa
      • Rest of MEA